BENICIA, Calif., March 16 /PRNewswire/ -- AcroMetrix Corporation announced that it has signed an agreement with Ambion Diagnostics, a division of Ambion, Inc. to manufacture Armored RNA-based products and distribute them to in vitro diagnostic laboratories and manufacturers. Under this agreement, Ambion Diagnostics will supply AcroMetrix with custom products based upon Armored RNA technology for further development and incorporation into calibrators, validation panels, proficiency panels and single point controls or standards.
"Armored RNA technology provides AcroMetrix with new capabilities for addressing customer needs in molecular diagnostics. We look forward to working with an innovative company like Ambion Diagnostics to bring the next generation of quality control products to the diagnostic market," said Michael J. Eck, CEO, AcroMetrix.
"We are very excited that AcroMetrix has chosen to incorporate Armored RNA Technology into its products. This agreement will expand the development and use of Ambion's unique Armored RNA technology into Molecular Diagnostics," said Dr. Jeff Williams, General Manager, Ambion Diagnostics.
Armored RNA technology is a novel system jointly invented and developed by Ambion and Cenetron for the packaging of RNA in bacteriophage coat proteins to protect and stabilize RNA. A major application for this technology is the production of RNA controls and standards for viral assays that withstand exposure to ribonucleases and long-term storage in plasma. RNA standards are essential to quantitative molecular diagnostic assays, and maintaining their integrity is crucial to obtaining accurate, reliable results. Ambion Diagnostics has recently released Armored RNA(R) Quant(TM), the next generation of quantitative standards that can be used to construct standard curves for quantitation of patient samples. Armored RNA Quant contains an accurate copy number of a specific target. The input copy number is referenced to a primary phosphate standard certified by the National Institute of Standards & Technology (NIST).
AcroMetrix, with facilities in Benicia, California and Alkmaar, Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com/.
About Ambion Diagnostics
Ambion Diagnostics, a division of Ambion, Inc., develops, manufactures and markets innovative products to detect diseases and enable the development of pharmaceuticals. It leverages RNA technologies and expertise of Ambion's Research Product Division to provide solutions for the clinical and healthcare industries. With a commitment to quality, Ambion Diagnostics is QSR/ISO compliant and FDA registered. For more information on Ambion Diagnostics please visit the company web site at http://www.ambiondx.com/.